Syros Pharmaceuticals Future Growth
How is Syros Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Future Growth Score2/6
Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
|Date||Revenue||Earnings||Free Cash Flow||Cash from Op||Avg. No. Analysts|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SYRS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SYRS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SYRS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SYRS's revenue (63.2% per year) is forecast to grow faster than the US market (7.1% per year).
High Growth Revenue: SYRS's revenue (63.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SYRS's Return on Equity is forecast to be high in 3 years time